4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference

About this update from 4d Molecular Therapeutics, Inc.

[{"type":"image","alt":"4D Molecular Therapeutics, Inc.","displaySize":"","headline":null,"caption":"4D Molecular Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/77c43650e1f3f7dcc5fea422c8ad89a8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OBgOYDeK6BG2g1ABskfhkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/77c43650e1f3f7dcc5fea422c8ad89a8","width":300,"height":85}},"lazy":false},{"type":"text","content":"EMERYVILLE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference. Members of the management team will also be available for one-on-one meetings.","length":486,"tagName":"p"},{"type":"text","content":"44th Annual J.P. Morgan Healthcare Conference","length":45,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Presentation Date:","length":18,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"Wednesday, Jan 14, 2026","length":23,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Presentation Time:","length":18,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"7:30 a.m. PT","length":12,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Webcast Link:","length":13,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"Webcast","length":7,"tagName":"p","attribs":{}}]}]}],"length":91},{"type":"text","content":"An archived copy of the webcast will be available for up to one year on the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events.","length":170,"tagName":"p"},{"type":"text","content":"About 4DMT ","length":11,"tagName":"p"},{"type":"text","content":"4DMT is a leading late-stage biotechnology company advancing...

More updates from 4d Molecular Therapeutics, Inc.